The effect of endovascular therap y on the exercise tolerance of peri pheral arterial disease

The effect of endovascular therap y on the exercise tolerance of peri pheral arterial disease - PAD-CPX study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033050

Enrollment

Registered

2018-06-20

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Symptomatic PAD patient (>=Rutherford : Category 2) refractory to t he standard non-invasive treatme nt (exercise and/or medical treat ment)

Exclusion criteria

Exclusion criteria: Clinical Lim ischemia people who do not bicycle Severe coronary artery disease Severe LV dysfunction Severe arrhythmia Pregnancy

Design outcomes

Primary

Measure	Time frame
The exercise tolerance (AT, peak VO2, 6MWD) We evaluate these parameters bef ore EVT, immedeately after EVT a nd 3 months after EVT.	—

Secondary

Measure	Time frame
The subjective symptoms (Rutherf ord class) The periperal circulation index (A BI, SPP) Other index of the cardiopulmona ry exercise test. Cardiac function.	—

Countries

Japan

Contacts

Public ContactMasahiro Toyama

Mito Kyodo General Hospital Cardiology Department

mt@mail1.accsnet.ne.jp029-231-2371

Outcome results